InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,967.35
(
1.77%
)
Post# of 252434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3204
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: drbio45 post# 102704

Friday, 08/27/2010 11:12:47 AM

Friday, August 27, 2010 11:12:47 AM

Post# of 252434
PLX4032 was designed to target a very specific mutation, the BRAF v600e mutation, they screen patients for this mutation.

It's not a matter of nexavar being a crappy multi kinase drug (to quote BTH's flippant remark), nexavar wasn't designed to hit that mutation.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up